World's Best Scientists 2026 revealed!
Yoshikazu Yuki

Yoshikazu Yuki

D-Index & Metrics

Immunology

D-Index
44
Citations
7975
World Ranking
4773
National Ranking
183

Yoshikazu Yuki publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yoshikazu Yuki sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 126 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yoshikazu Yuki D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshikazu Yuki sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yoshikazu Yuki is affiliated with the University of Tokyo in Japan, focusing on research in medicine and biotechnology. Their work spans multiple subfields including infectious diseases, epidemiology, molecular biology, immunology, and biotechnology. The scientist's main fields of study encompass medicine and biochemistry, genetics, and molecular biology, with a particular emphasis on viral gastroenteritis research and epidemiology.

Their research covers a range of topics, including:

  • Viral gastroenteritis research and epidemiology
  • Pneumonia and respiratory infections
  • Transgenic plants and applications
  • Bacterial infections and vaccines
  • Respiratory viral infections research
  • SARS-CoV-2 and COVID-19 research
  • Viral infections and immunology research

Yuki has published extensively, with recent papers highlighting diverse areas within immunology and infectious diseases. Key publications include:

  • "A review of criteria strictness in 'Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials,'" 2023, Vaccine
  • "Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy against Pathobionts," 2020, Cell Host & Microbe
  • "Pancreatic glycoprotein 2 is a first line of defense for mucosal protection in intestinal inflammation," 2021, Nature Communications
  • "Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial," 2021, The Lancet Microbe
  • "A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci," 2021, Vaccine

The scientist frequently publishes in prominent venues, with multiple publications appearing in Vaccine. Other venues include Frontiers in Plant Science, Cell Host & Microbe, Trends in Molecular Medicine, and Nature Communications.

Yuki collaborates regularly with several coauthors, including:

  • Hiroshi Kiyono
  • Rika Nakahashi-Ouchida
  • Kohtaro Fujihashi
  • Shiho Kurokawa
  • Shintaro Sato

Yuki's research contributes to understanding and developing vaccines, treatments, and immunological insights in the context of infectious diseases and molecular biology. Their multidisciplinary approach bridges clinical and molecular perspectives within healthcare and biotechnology domains.

Best Publications

  • Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines

    Tomonori Nochi;Yoshikazu Yuki;Haruko Takahashi;Shin Ichi Sawada

  • Intestinal villous M cells: An antigen entry site in the mucosal epithelium

    Myoung Ho Jang;Mi Na Kweon;Mi Na Kweon;Mi Na Kweon;Koichi Iwatani;Masafumi Yamamoto;Masafumi Yamamoto;Masafumi Yamamoto

  • Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues

    Frederik W. van Ginkel;Raymond J. Jackson;Yoshikazu Yuki;Jerry R. McGhee

  • Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination

    Tomonori Nochi;Hidenori Takagi;Yoshikazu Yuki;Lijun Yang

  • A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses

    Hidenori Takagi;Takachika Hiroi;Lijun Yang;Yoshifumi Tada

  • New generation of mucosal adjuvants for the induction of protective immunity.

    Yoshikazu Yuki;Hiroshi Kiyono

  • Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis

    Takashi Obata;Yoshiyuki Goto;Jun Kunisawa;Shintaro Sato

  • A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses.

    Tomonori Nochi;Yoshikazu Yuki;Akiko Matsumura;Mio Mejima

  • Comprehensive Gene Expression Profiling of Peyer’s Patch M Cells, Villous M-Like Cells, and Intestinal Epithelial Cells

    Kazutaka Terahara;Masato Yoshida;Osamu Igarashi;Tomonori Nochi

  • Novel vaccine development strategies for inducing mucosal immunity

    Fujkuyama Y;Tokuhara D;Kataoka K;Gilbert Rs

  • Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae

    Il Gyu Kong;Il Gyu Kong;Ayuko Sato;Yoshikazu Yuki;Tomonori Nochi

  • Plant-based vaccines for animals and humans: recent advances in technology and clinical trials.

    Natsumi Takeyama;Hiroshi Kiyono;Yoshikazu Yuki

  • Antigen-sampling cells in the salmonid intestinal epithelium.

    Bjørn Fuglem;Emilio Jirillo;Inge Bjerkås;Hiroshi Kiyono

  • Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine

    Daisuke Tokuhara;Yoshikazu Yuki;Tomonori Nochi;Toshio Kodama

  • Challenges in mucosal vaccines for the control of infectious diseases

    Tatsuhiko Azegami;Yoshikazu Yuki;Hiroshi Kiyono

  • Mucosal vaccines: novel advances in technology and delivery.

    Yoshikazu Yuki;Hiroshi Kiyono

  • Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques

    Y Fukuyama;Y Yuki;Y Katakai;N Harada

  • Transcription factor Spi-B–dependent and –independent pathways for the development of Peyer’s patch M cells

    S Sato;S Kaneto;N Shibata;Y Takahashi

  • Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection

    Daisuke Tokuhara;Beatriz Álvarez;Mio Mejima;Tomoko Hiroiwa

  • A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.

    Tomonori Nochi;Yoshikazu Yuki;Yuko Katakai;Hiroaki Shibata

  • A review of criteria strictness in "Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials".

    Unknown

Frequent Co-Authors

Hiroshi Kiyono
Hiroshi Kiyono University of Tokyo
Tomonori Nochi
Tomonori Nochi Tohoku University
Kohtaro Fujihashi
Kohtaro Fujihashi University of Alabama at Birmingham
Kazunari Akiyoshi
Kazunari Akiyoshi Kyoto University
Shintaro Sato
Shintaro Sato Osaka University
Shunji Kozaki
Shunji Kozaki Osaka Metropolitan University
Jun Kunisawa
Jun Kunisawa National Institutes of Biomedical Innovation, Health and Nutrition
Hideo Tsukada
Hideo Tsukada Hamamatsu Photonics (Japan)
Satoshi Uematsu
Satoshi Uematsu Osaka Metropolitan University
Mi-Na Kweon
Mi-Na Kweon University of Ulsan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career avenues. Many professionals consider advancing their qualifications through specialized nursing programs that complement immunology expertise.

For example, transitioning to an advanced practice role might involve obtaining an acute care certification for FNP. This specialization enables Nurse Practitioners to handle complex patient conditions, including immunological disorders.

Accelerated pathways, such as those found in accelerated FNP programs, offer a faster route to advanced practice nursing roles. These programs are designed to build on existing healthcare knowledge and can enhance career prospects in immunology-related fields.

For those starting fresh or transitioning from other backgrounds, online accelerated nursing programs for non nurses provide flexible options to enter nursing with a focus on areas relevant to immunology. Similarly, exploring easiest accelerated nursing programs to get into can help prospective students find accessible entry points into the nursing profession.

These related online degrees can enhance an immunology career by broadening clinical skills and opening doors to patient care, research, and healthcare leadership.

Best Scientists Citing Yoshikazu Yuki

Trending Scientists